tradingkey.logo
tradingkey.logo

Hims & Hers Health Inc

HIMS
31.690USD
-2.180-6.44%
終値 01/09, 16:00ET15分遅れの株価
7.21B時価総額
52.92直近12ヶ月PER

Hims & Hers Health Inc

31.690
-2.180-6.44%

詳細情報 Hims & Hers Health Inc 企業名

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.

Hims & Hers Health Incの企業情報

企業コードHIMS
会社名Hims & Hers Health Inc
上場日Sep 09, 2019
最高経営責任者「CEO」Dudum (Andrew)
従業員数1637
証券種類Ordinary Share
決算期末Sep 09
本社所在地2269 Chestnut St
都市SAN FRANCISCO
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号94123
電話番号14158510195
ウェブサイトhttps://www.forhims.com/
企業コードHIMS
上場日Sep 09, 2019
最高経営責任者「CEO」Dudum (Andrew)

Hims & Hers Health Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.50M
+73709.00%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
171.83K
+18604.00%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
98.05K
-3084.00%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+9935.00%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+6623.00%
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Dr. Delos Cosgrove, M.D.
Dr. Delos Cosgrove, M.D.
Independent Director
Independent Director
--
--
Ms. Andrea Perez
Ms. Andrea Perez
Independent Director
Independent Director
--
--
Mr. David Wells
Mr. David Wells
Lead Independent Director
Lead Independent Director
--
--
Mr. Mike Chi
Mr. Mike Chi
Chief Operating Officer
Chief Operating Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.50M
+73709.00%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
171.83K
+18604.00%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
98.05K
-3084.00%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+9935.00%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+6623.00%
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
事業別USD
会社名
収益
比率
Online
589.10M
98.35%
Wholesale
9.88M
1.65%
地域別USD
会社名
収益
比率
United States
598.98M
100.00%
事業別
地域別
事業別USD
会社名
収益
比率
Online
589.10M
98.35%
Wholesale
9.88M
1.65%

株主

更新時刻: Sat, Nov 15
更新時刻: Sat, Nov 15
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
10.07%
The Vanguard Group, Inc.
8.88%
Capital World Investors
8.57%
JP Morgan Asset Management
5.87%
Farallon Capital Management, L.L.C.
4.90%
他の
61.71%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
10.07%
The Vanguard Group, Inc.
8.88%
Capital World Investors
8.57%
JP Morgan Asset Management
5.87%
Farallon Capital Management, L.L.C.
4.90%
他の
61.71%
種類
株主統計
比率
Investment Advisor
53.26%
Investment Advisor/Hedge Fund
13.37%
Research Firm
12.70%
Hedge Fund
10.85%
Individual Investor
6.37%
Pension Fund
1.81%
Bank and Trust
1.46%
Sovereign Wealth Fund
0.74%
Private Equity
0.23%

機関投資家保有株

更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
1031
207.42M
94.59%
-8.21M
2025Q3
970
195.39M
89.11%
-889.66K
2025Q2
893
201.00M
92.37%
-34.62M
2025Q1
847
185.19M
85.97%
-48.88M
2024Q4
739
195.19M
91.41%
-9.62M
2024Q3
627
167.49M
80.36%
-35.34M
2024Q2
588
165.89M
79.48%
-12.74M
2024Q1
503
156.70M
75.98%
-10.05M
2023Q4
463
153.90M
75.37%
-26.71M
2023Q3
444
160.41M
78.97%
-33.55M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
22.09M
10.07%
+414.70K
+1.91%
Sep 30, 2025
The Vanguard Group, Inc.
19.47M
8.88%
+841.15K
+4.51%
Sep 30, 2025
Capital World Investors
18.78M
8.57%
+223.89K
+1.21%
Sep 30, 2025
JP Morgan Asset Management
12.87M
5.87%
+12.26M
+2026.69%
Sep 30, 2025
Farallon Capital Management, L.L.C.
10.75M
4.9%
+2.53M
+30.84%
Sep 30, 2025
Dudum (Andrew)
9.50M
4.33%
+73.71K
+0.78%
Dec 15, 2025
Renaissance Technologies LLC
9.10M
4.15%
+2.23M
+32.42%
Sep 30, 2025
Goldman Sachs & Company, Inc.
8.54M
3.9%
+998.73K
+13.24%
Sep 30, 2025
State Street Investment Management (US)
7.17M
3.27%
+132.38K
+1.88%
Sep 30, 2025
Morgan Stanley & Co. LLC
5.93M
2.71%
+1.88M
+46.43%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
First Trust Nasdaq Lux Digi Health Solutions ETF
3.83%
Global X HealthTech ETF
3.75%
Amplify Weight Loss Drug & Treatment ETF
3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
3.66%
YieldMax Ultra Option Income Strategy ETF
2.96%
Invesco S&P MidCap 400 Pure Growth ETF
2.4%
State Street SPDR S&P Health Care Services ETF
1.94%
Amplify Online Retail ETF
1.85%
Invesco S&P MidCap 400 GARP ETF
1.65%
VanEck Social Sentiment ETF
1.53%
詳細を見る
First Trust Nasdaq Lux Digi Health Solutions ETF
比率3.83%
Global X HealthTech ETF
比率3.75%
Amplify Weight Loss Drug & Treatment ETF
比率3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
比率3.66%
YieldMax Ultra Option Income Strategy ETF
比率2.96%
Invesco S&P MidCap 400 Pure Growth ETF
比率2.4%
State Street SPDR S&P Health Care Services ETF
比率1.94%
Amplify Online Retail ETF
比率1.85%
Invesco S&P MidCap 400 GARP ETF
比率1.65%
VanEck Social Sentiment ETF
比率1.53%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Hims & Hers Health Incの上位5名の株主は誰ですか?

Hims & Hers Health Incの上位5名の株主は以下のとおりです。
BlackRock Institutional Trust Company, N.A.は22.09M株を保有しており、これは全体の10.07%に相当します。
The Vanguard Group, Inc.は19.47M株を保有しており、これは全体の8.88%に相当します。
Capital World Investorsは18.78M株を保有しており、これは全体の8.57%に相当します。
JP Morgan Asset Managementは12.87M株を保有しており、これは全体の5.87%に相当します。
Farallon Capital Management, L.L.C.は10.75M株を保有しており、これは全体の4.90%に相当します。

Hims & Hers Health Incの株主タイプ上位3種は何ですか?

Hims & Hers Health Incの株主タイプ上位3種は、
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Capital World Investors

Hims & Hers Health Inc(HIMS)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Hims & Hers Health Incの株式を保有している機関は1031社あり、保有株式の総市場価値は約207.42Mで、全体の94.59%を占めています。2025Q3と比較して、機関の持ち株は5.48%増加しています。

Hims & Hers Health Incの最大の収益源は何ですか?

FY2025Q3において、Online部門がHims & Hers Health Incにとって最大の収益を生み出しており、その金額は589.10Mで、全収益の98.35%を占めています。
KeyAI